Prognostic significance of focal neuroendocrine differentiation in prostate cancer: Cases with autopsy-verified cause of death
Author:
Open Access
- 1 January 2010
- journal article
- research article
- Published by Medknow in Indian Journal of Urology
- Vol. 26 (1) , 41-5
Abstract
Aims : This study was designed to evaluate the prognostic significance of focal chromogranin A (cgA) expression in prostate cancer in a series of cases with autopsy-verified cause of death. Methods and Results : Seventy seven autopsy-verified cases of prostate cancer were identified, 41 cases with metastatic disease and 36 with nonmetastatic disease at autopsy. Immunohistochemical analysis for cgA was performed in 40 cases on the archived diagnostic biopsies taken during the patients' lifetime. After exclusion of a single case of carcinoid tumor, 14 of the 18 (78%) metastatic and none of the 21 (0%) nonmetastatic tumors showed focal neuroendocrine differentiation (NED). The Gleason score and focal cgA expression further increased the accuracy of the prediction of the outcome, as all the cases with focal NED associated with high Gleason score had metastatic disease in contrast to cases without cgA-expression and low Gleason score, all of which were non-metastatic. Conclusions : Focal NED seems to be a powerful negative prognostic parameter in prostate adenocarcinomas. The outcome of the disease in prostate cancer can be accurately predicted based on focal NED of the tumor cells either alone or in combination with Gleason score.Keywords
This publication has 28 references indexed in Scilit:
- Neuroendocrine Differentiation in Prostate Cancer: From Lab to BedsideUrologia Internationalis, 2007
- Prediction of extracapsular extension of prostate cancer based on systematic core biopsiesScandinavian Journal of Urology and Nephrology, 2006
- Neuroendocrine Differentiation in Prostate Cancer: Implications for New Treatment ModalitiesEuropean Urology, 2005
- The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.2005
- Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinomaThe Prostate, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- HER2 Protein Expression and Gene Amplification in Androgen-Independent Prostate CancerAmerican Journal of Clinical Pathology, 2001
- The Prognostic Value of Neuroendocrine Differentiation in Adenocarcinoma of the Prostate in Relation to Progression of Disease After Endocrine TherapyJournal of Urology, 1997
- The proliferative function of basal cells in the normal and hyperplastic human prostateThe Prostate, 1994
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987